16 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
to provide a fixed component of compensation reflecting the executive’s skill set, experience, role and responsibilities.
Effective as of January 1, 2023
S-3
EX-4.4
ALGS
Aligos Therapeutics Inc
4 Nov 21
Shelf registration
4:57pm
, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent
DEF 14A
c0tvl0pg yay0stu8
27 Apr 21
Definitive proxy
4:15pm
424B4
fug20n9j jvdj
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
EX-10.2
s8xzq6j5533fgo
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.1
i1u81 8b79
25 Sep 20
IPO registration
5:27pm
S-1
vx54 q5dz5
25 Sep 20
IPO registration
5:27pm
DRS
hbz0ig dik
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next